Inhibitory effect of new antibiotic, pradimincin A on infectivity, cytopathic effect and replication of human immunodeficiency virus in vitro. 1988

A Tanabe, and H Nakashima, and O Yoshida, and N Yamamoto, and O Tenmyo, and T Oki
Department of Virology and Parasitology, Yamaguchi University School of Medicine, Japan.

UI MeSH Term Description Entries
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003588 Cytopathogenic Effect, Viral Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses. Cytopathic Effect, Viral,Viral Cytopathogenic Effect,Cytopathic Effects, Viral,Cytopathogenic Effects, Viral,Effect, Viral Cytopathic,Effect, Viral Cytopathogenic,Effects, Viral Cytopathic,Effects, Viral Cytopathogenic,Viral Cytopathic Effect,Viral Cytopathic Effects,Viral Cytopathogenic Effects
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D018943 Anthracyclines Organic compounds that have a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine. Anthracycline

Related Publications

A Tanabe, and H Nakashima, and O Yoshida, and N Yamamoto, and O Tenmyo, and T Oki
June 1987, Antimicrobial agents and chemotherapy,
A Tanabe, and H Nakashima, and O Yoshida, and N Yamamoto, and O Tenmyo, and T Oki
March 1987, Antiviral research,
A Tanabe, and H Nakashima, and O Yoshida, and N Yamamoto, and O Tenmyo, and T Oki
September 2000, The Journal of antibiotics,
A Tanabe, and H Nakashima, and O Yoshida, and N Yamamoto, and O Tenmyo, and T Oki
May 1994, The Journal of antibiotics,
A Tanabe, and H Nakashima, and O Yoshida, and N Yamamoto, and O Tenmyo, and T Oki
August 1988, Proceedings of the National Academy of Sciences of the United States of America,
A Tanabe, and H Nakashima, and O Yoshida, and N Yamamoto, and O Tenmyo, and T Oki
May 1996, Journal of virological methods,
A Tanabe, and H Nakashima, and O Yoshida, and N Yamamoto, and O Tenmyo, and T Oki
August 1988, Proceedings of the National Academy of Sciences of the United States of America,
A Tanabe, and H Nakashima, and O Yoshida, and N Yamamoto, and O Tenmyo, and T Oki
September 1993, Nihon rinsho. Japanese journal of clinical medicine,
A Tanabe, and H Nakashima, and O Yoshida, and N Yamamoto, and O Tenmyo, and T Oki
July 1987, Antiviral research,
A Tanabe, and H Nakashima, and O Yoshida, and N Yamamoto, and O Tenmyo, and T Oki
February 1990, Biochemical and biophysical research communications,
Copied contents to your clipboard!